Compare
Lilly (Eli) vs Prestige Consumer Healthcare (LLY vs PBH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Lilly (Eli) (LLY) returned +46.2% and Prestige Consumer Healthcare (PBH) -28.2%; so far this year the figures are +26.0% and -30.3%.
Lilly (Eli) is the larger company by market value, about 624.4 times the size of Prestige Consumer Healthcare.
On trailing earnings, LLY trades at 43.9 times and PBH at 13.3 times.
Revenue grew +45.5% at LLY and +5.1% at PBH over the last year.
LLY yields 0.49%. PBH pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| LLY | PBH | |
|---|---|---|
| Price | $1,354.00 | $42.98 |
| 1-day | -0.79% | -3.02% |
| YTD | +25.99% | -30.33% |
| 1 year | +46.25% | -28.16% |
| 3 years | +144.20% | -27.78% |
| Market cap | $1.27T | $2.0B |
| P/E | 43.9 | 13.3 |
| P/S | 14.73 | 1.75 |
| P/B | 31.63 | 1.05 |
| Revenue growth | +45.50% | +5.10% |
| EPS growth | +50.70% | -19.80% |
| Gross margin % | 83.6 | 52.5 |
| Net margin % | 31.9 | 13.3 |
| ROE % | 68.5 | 8.0 |
| Debt / equity | 1.23 | 1.07 |
| FCF yield % | 2.4 | 10.5 |
| Dividend yield % | 0.49 | — |
| Beta | 0.29 | 0.45 |
| RSI (14) | 61.1 | 36.7 |
| Technical rating |